Cerebrospinal fluid biomarkers in parkinsonian conditions: an update and future directions

Parkinsonian diseases comprise a heterogeneous group of neurodegenerative disorders, which show significant clinical and pathological overlap. Accurate diagnosis still largely relies on clinical acumen; pathological diagnosis remains the gold standard. There is an urgent need for biomarkers to diagn...

Descripción completa

Detalles Bibliográficos
Autores principales: Magdalinou, Nadia, Lees, Andrew J, Zetterberg, Henrik
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2014
Materias:
Neurodegeneration
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4173749/
https://www.ncbi.nlm.nih.gov/pubmed/24691581
http://dx.doi.org/10.1136/jnnp-2013-307539

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4173749/
https://www.ncbi.nlm.nih.gov/pubmed/24691581
http://dx.doi.org/10.1136/jnnp-2013-307539

Ejemplares similares